Apheresis technology adoption is on rise owing to the introduction of
advanced therapies like stem cell therapy, radiotherapy and
immunoglobulin therapy. Employing these therapies to prevent chronic
diseases encourages adoption of apheresis procedures which boosts the
global apheresis market.
Apheresis technology is gaining support from authorities of different
regions like North America and Europe. Government of these regions are
running supportive programs such as Medicare, employee insurance
programs, Medicaid and Veterans Health Administration to address issues
regarding the high cost of apheresis procedures. Paid plans have been
introduced in blood donation segment by private blood collection centers
in order to attract donors. Hospitals are increasingly adopting the
apheresis procedures. Apheresis equipment are used in various activities
like collection and storage of the blood component that are required.
Japan embraces technological advancements
Latest
Fcat.MR report predicts that the global apheresis market will be twice
the current volume in the forecast period 2020-2025. North America leads
market on the back drop of technological advancements and government
support. The quality of health care services have improved considerably
in the region. This increases the reliance and trust of the patients on
hospitals. Major stake holders have initiated various development
initiatives to create advanced apheresis products which attracts
patients and expands the patient pool in North America. All the above
factors positively influence apheresis market growth in North America.
Its market is expected to grow at ̴10% CAGR during the forecast
period.
Manufacturers
in Japan are embracing technological advancements to foster innovations
in order to gain greater penetration in market. The ongoing development
of apheresis products in Japan strengthens the market in Asia pacific.
Reimbursement strategies have been introduced by the market players in
developing economies to strengthen their foot hold. Players are
strategizing on the grounds of cost effectiveness to expand their market
base in the region.
New revenue sources pose challenge
The
unmet demand of blood components in the health care sector drive the
global apheresis market. Demographic shift from single dose apheresis
towards double dose has positively influenced the yield of blood
components. This shift has compelled the manufactures to come up with
the procedures to segregate multiple components at a time. Advanced
products like immunosorbent and plasma separators are introduced in the
market to serve this purpose. Double dose apheresis procedures are
highly popular in region including Japan US and Germany. Disposables are
the most preferred in the global market in devices on the backdrop of
easy differentiation of different types of products including blood
lines and tubing. The growing usage of such products generate lucrative
opportunities in global market and increase the sale of disposable
products.
New revenue channels present numerous challenges before
the apheresis market. Lack of skilled professional is a hurdle in the
market growth. Also, the market lacks expert operators to handle
apheresis equipment with technological advancements. Expert’s scarcity
automatically increases the price of expert resources. The cost concerns
about apheresis procedure in developing and under developed economies
is expected to shrink the opportunities for market players.